Published
A Review on Stability Development Guidelines and Impurities Profile Consideration in Solid Oral Dosage Form
Published in June 2020 Issue 3 (Vol. 10, Issue 3, 2020)

Abstract
In the pharmaceutical industry an impurity is considered, defined the any other organic material besides the drug substance or pharmaceutical ingredients. The impurity may be formed during the formulation or upon aging of two APIs in medicines. Stability testing is an integral part of pharmaceutical development. The primary purpose of stability testing is to provide supporting evidence on stability behavior of pharmaceutical drug products. Stability is the capacity of a drug product to remain within specifications established to ensure its identity, strength, quality and purity.
Authors (4)
Dnyaneshwar Bharat Kadlag
View all publications →Santosh Dattu Navale
View all publications →S. B. Patil
View all publications →C. D. Upasani
View all publications →Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Article Information
Published in:
June 2020 Issue 3 (Vol. 10, Issue 3, 2020)- Article ID:
- AJPTR103008
- Paper ID:
- AJPTR-01-000189
- Published Date:
- 2020-06-01
Article Impact
Views:1,960
Downloads:1,984
scite_
Smart Citations
0Citing Publications
0Supporting
0Mentioning
0Contrasting
View Citations
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
How to Cite
Bharat, D., & Dattu, S. & B., S. & D., C. (2020). A Review on Stability Development Guidelines and Impurities Profile Consideration in Solid Oral Dosage Form. American Journal of PharmTech Research, 10(3), xx-xx. DOI:https://doi.org/10.46624/ajptr.2020.v10.i3.008
Article Actions
More from this Issue
Pharmacological Potential Of A Resourceful Heterocycle: Pyrazoline – A Review
Cinsila Vincent, K.Krishn...Read more →
Synthesis of 2-(Bis(2-chloroethyl)amino)-N-(4-((3-oxobenzofuran-2(3H)-ylidene)methyl)phenyl)acetamide Derivatives on Basis of Benzaldehydes and Acetophenones As Possible Alkylating Anticancer Agents
Agasa Ramu Mahesh, Vedigo...Read more →
Cleaning Validation In Pharmaceutical Industry
Archana B. Chavhan, Shubh...Read more →

